Amanta Healthcare IPO: Allotment Status, GMP Trends, and Key Details You Need to Know

The buzz around the Amanta Healthcare IPO has been strong, and investors are now eagerly waiting for the allotment status. With the issue seeing overwhelming demand and a healthy grey market premium (GMP), this IPO has captured market attention. Let’s break down everything you need to know—clearly, simply, and in story-like flow.

Market Performance and Allotment Update

The Amanta Healthcare IPO allotment is expected to be finalized today, September 4.

• The IPO received massive investor interest, getting subscribed 82.52 times during the three days of public bidding.
  
  
• This kind of oversubscription shows how strongly the market responded to the offer.
  
  

Investors who applied can soon check whether they have secured shares.

IPO Details at a Glance

Amanta Healthcare, a pharmaceutical company focused on sterile liquid products and parenteral solutions, launched its IPO with the following key numbers:

• Issue Size: ₹126 crore (entirely fresh issue)
  
  
• Shares Offered: 1 crore equity shares
  
  
• Price Band: ₹120 – ₹126 per share
  
  
• Lot Size: Minimum bid of 119 shares (₹14,994 at upper band)
  
  

The subscription numbers reflected investor confidence, making it one of the most talked-about mid-sized IPOs recently.

Pre-IPO Anchor Investment

Before opening to the public, Amanta Healthcare secured strong backing from institutional investors:

• ₹37.8 crore was raised on August 29 through anchor investors.
  
  
• 30 lakh shares were allotted at ₹126 per share.
  
  
• Out of this, 7.93 lakh shares went to Bandhan Mutual Fund (Small Cap Fund).
  
  

This anchor placement added credibility and brought in early momentum for the IPO.

Company Plans and Use of Proceeds

Amanta Healthcare has clear plans for utilizing the IPO funds. The company is valued at nearly ₹500 crore and intends to use the fresh capital for expansion.

Here’s how the funds are allocated:

• ₹70 crore: Setting up a new SteriPort manufacturing line.
  
  
• ₹30.13 crore: Establishing a new small-volume parenteral (SVP) line at Hariyala, Gujarat.
  
  
• Remaining funds: General corporate purposes.
  
  

These expansions aim to strengthen Amanta Healthcare’s manufacturing capabilities and future growth.

Final Word

The Amanta Healthcare IPO stands out for its strong subscription figures and visible interest in the grey market. With allotments expected today, all eyes are now on the listing.

• Subscription: 82.52 times
  
  
• IPO Size: ₹126 crore
  
  
• Anchor Investment: ₹37.8 crore
  
  

As the story unfolds, Amanta Healthcare’s journey from allotment to listing will remain closely tracked by the market.